Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2004-07-16
2009-10-06
Badio, Barbara P (Department: 1612)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
active
07598234
ABSTRACT:
A series of novel steroid derivatives are described. The steroid derivatives are antibacterial agents. The steroid derivatives also act to sensitize bacteria to other antibiotics including erythromycin and novobiocin.
REFERENCES:
patent: 3519714 (1970-07-01), Hughes et al.
patent: 4029775 (1977-06-01), Saltzman
patent: 4158707 (1979-06-01), Steffen et al.
patent: 4192871 (1980-03-01), Phillipps et al.
patent: 4299726 (1981-11-01), Crews et al.
patent: 4565810 (1986-01-01), Castagnola et al.
patent: 4892868 (1990-01-01), Castagnola et al.
patent: 4981983 (1991-01-01), Castagnola et al.
patent: 5268272 (1993-12-01), Mullner et al.
patent: 5364632 (1994-11-01), Benita et al.
patent: 5446026 (1995-08-01), Ruff et al.
patent: 5583239 (1996-12-01), Regen
patent: 5622944 (1997-04-01), Hale et al.
patent: 5637691 (1997-06-01), Frye et al.
patent: 5763430 (1998-06-01), Zasloff
patent: 5804563 (1998-09-01), Still et al.
patent: 5834453 (1998-11-01), Regen
patent: 6143738 (2000-11-01), Zasloff
patent: 6350738 (2002-02-01), Savage et al.
patent: 6486148 (2002-11-01), Savage et al.
patent: 6767904 (2004-07-01), Savage et al.
patent: 0 113 998 (1984-07-01), None
patent: 0 124 068 (1984-11-01), None
patent: 0 135 782 (1985-05-01), None
patent: 0 168 229 (1986-01-01), None
patent: WO 94/20520 (1994-09-01), None
patent: WO 95/19567 (1995-07-01), None
patent: WO 95/24415 (1995-09-01), None
patent: WO 96/08270 (1996-03-01), None
patent: WO 99/31124 (1999-06-01), None
Barnes et al., “Preparation and Characterisation of Permethylated Derivatives of Bile Acids, and Their Application to Gas Chromatographic Analysis”, J. of Chromatography, 183, (1980), 269-276.
Bellini et al., “Antimicrobial Activity of Cholane Compounds Cheno and Ursodeoxycholic Acids Derivatives Part II)”, Eur. J. Med. Chem.—Chem. Ther. 1983-18, No. 2, pp. 191-195.
Bellini et al., “Antimicrobial Activity of Cholane Compounds Cholic and Deoxycholic Acids Derivatives (Part I)”, Eur. J. Med. Chem.—Chem. Ther. 1983-18, No. 2, pp. 185-190.
Bowe et al., “Design of Compounds That Increase the Asorption of Polar Molecules”, Proc. Natl. Acad. Sci., USA (1997), pp. 12218-12223.
Boyce et al., “Peptidosteroidal Receptors for Opioid Peptides, Sequence-Selective Binding Using a Synthetic Receptor Library”, J. Am. Chem. Soc., 1994, 116, 7955-7956.
Broderick et al., “The ‘Triamino-analogue’ of Methyl Cholate; A Facial Amphiphile and Scaffold with Potential for Combinatorial and Molecular Recognition Chemistry”, Tetrahedron Letters, 39 (1998) 6083-6086.
Cheng et al., “Sequence-Selective Peptide Binding with a Peptido-A,B-trans-steroidal Receptor Selected from an Encoded Combinatorial Receptor Library”, J. Am. Chem. Soc., 1996, 118, 1813-1814.
Deng et al., “A Synthetic Loophole that Recognizes Negatively Charged Phospholipid Membranes”, J. Am. Chem. Soc. 1996, 118, 8975-8976.
Ding et al., “Correlation of the Antibacterial Activities of Cationic Peptide Antibiotics and Cationic Steroid Antibiotics”, J. Med. Chem., pp. 663-669, vol. 45, Jan. 31, 2002.
Guan et al., “Preparation and Characterization of Cholic Acid-Derived Antimicrobial Agents with Controlled Stabilities”, Org. Lett., vol. 2, No. 18, pp. 2837-2840, 2000.
H. Peter Nestler, “Sequence-Selective Nonmacrocyclic Two-Armed Receptors for Peptides”, Molecular Diversity, 2 (1996) 35-40.
Hsieh et al., “Structural Effects in Novel Steroidal Polyamine-DNA Binding”, J. Am. Chem. Soc., vol. 116, No. 26, 1994, pp. 12077-12079.
Hsieh et al., “Synthesis and DNA Binding Properties of C3-, C12-, and C24- Substituted Amino-Steroids Derived from Bile Acids”, Bioorganic & Medicinal Chemistry, vol. 3, No. 6, pp. 823-838, 1995.
Jones et al., The synthesis and characterization of analogs of the antimicrobial compound sqalamine: 6β-hdroxy-3-aminosterols synthesized from hyodeoxycholic acid, Steroids, pp. 565-571, vol. 61, Oct. 1996.
Li et al., “Design and Synthesis of Potent Sensitizers of Gram-Negative Bacteria Based on a Cholic Acid Scaffolding”, J. Am. Chem. Soc., vol. 120, No. 12, Apr. 1, 1998, 2961-62.
Li et al., “Preparation of Amine-Functionalized Cholic Acid Derivatives for Use as Lipid A Binding Agents”, Book of Abstracts, 214th ACS National Meeting, Sep. 7-11, 1997, Poster Session.
Moore et al., “Squalamine: An Aminosterol Antibiotic From the Shark”, Proc. Natl. Acad. Sci. USA, vol. 90, pp. 1354-1358, Feb. 1993.
Paul B. Savage, “Design, Synthesis and Characterization of Cationic Peptide and Steroid Antibiotics”, Eur. J. Org. Chem., pp. 759-768, 2002.
Paul B. Savage, “Multidrug-Resistant Bacteria: Overcoming Antibiotic Permeability Barriers of Gram-Negative Bacteria”, Ann Med, vol. 33, pp. 167-171, 2001.
Savage et al., “Cholic Acid Derivatives: Novel Antimicrobials”, Exp. Opin. Invest. Drugs, vol. 9, pp. 263-272, 2000.
Schmidt et al., “Activities of Cholic Acid-Derived Antimicrobial Agents Against Multidrug-Resistant Bacteria”, Journal of Antimicrobial Chemotherapy, vol. 47, pp. 671-674, 2001.
Walker et al., “Cationic Facial Amphiphiles: A Promising Class of Transfection Agents”, Proc. Natl. Acad. Sci., vol. 93, pp. 1585-1590, Feb. 1995.
Wess et al., “The Design and Synthesis of a Scaffold for Combinatorial Chemistry Based on Bile Acid”, Angew. Chem. Int. Ed. Eng. 1996, 33, No. 19, pp. 2222-2225.
Li et al., “Antimicrobial activities of amine-and guanidine-functionalized cholic acid derivatives,” Antimicrob. Agents Chemother., 43(6), 1347-1349 (1999).
Li et al., “Incremental Conversion of Outer-Membrane Permeabilizers into Potent Antibiotics for Gram-Negative Bacteria,” Journal of the American Chemical Society, vol. 121, No. 5, pp. 931-940 (Feb. 1999).
Li et al., “Short Synthesis of Triamine Derivatives of Cholic Acid,”Tetrahedron Letters, vol. 40, No. 10, pp. 1861-1864 (Mar. 5, 1999).
Office Action dated Nov. 13, 2008 re U.S. Appl. No. 11/669,803.
Savage et al., “Antibacterial Properties of Cationic Steroid Antibiotics, FEMS Microbiology Letters,” 217:1-7 (2002).
Li Chunhong
Savage Paul B.
Badio Barbara P
Brigham Young University
Fish & Richardson P.C.
LandOfFree
Steroid derived antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Steroid derived antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroid derived antibiotics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4137957